Endocrinology
3 drugs are in development for Diabetes.
- Companies
- 3
- Clinical trials
- 38
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Diabetes pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Preclinical(3)
| Drug | Company |
|---|---|
| biosimilar insulin aspart | LANNETT CO INC (LCI) |
| oral insulin | ORAMED PHARMACEUTICALS INC. (ORMP) |
| oral-lyn | GENEREX BIOTECHNOLOGY CORP (GNBT) |
About this indication
Diabetes context
Endocrinology·MeSH: Diabetes Mellitus (D003920)
Narrower concept of MeSH descriptor Diabetes Mellitus
Prevalence
10700.0 / 100K
Incidence
600.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Diabetes?
BioSniper tracks 3 drugs in development for Diabetes across 3 companies.
How many clinical trials target Diabetes?
There are 38 clinical trials targeting Diabetes tracked by BioSniper.
What is the prevalence of Diabetes?
The estimated prevalence of Diabetes is approximately 10700.0 per 100,000 population.